Myomo (MYO) Revenue (QoQ) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Myomo | 44.63 Mn | 26.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 4.54% |
| Jun 30, 2025 | -1.83% |
| Mar 31, 2025 | -18.53% |
| Dec 31, 2024 | 31.07% |
| Sep 30, 2024 | 22.43% |
| Jun 30, 2024 | 100.32% |
| Mar 31, 2024 | -21.07% |
| Dec 31, 2023 | -6.36% |
| Sep 30, 2023 | -14.75% |
| Jun 30, 2023 | 72.88% |
| Mar 31, 2023 | -14.72% |
| Dec 31, 2022 | 1.85% |
| Sep 30, 2022 | 7.90% |
| Jun 30, 2022 | -4.92% |
| Mar 31, 2022 | -4.06% |
| Dec 31, 2021 | -8.04% |
| Sep 30, 2021 | 41.22% |
| Jun 30, 2021 | 32.86% |
| Mar 31, 2021 | -38.35% |
| Dec 31, 2020 | 96.71% |
| Sep 30, 2020 | 124.40% |
| Jun 30, 2020 | -14.83% |
| Mar 31, 2020 | -33.71% |
| Dec 31, 2019 | 150.68% |
| Sep 30, 2019 | -31.09% |
| Jun 30, 2019 | 6.06% |
| Mar 31, 2019 | -6.69% |
| Dec 31, 2018 | 46.08% |
| Sep 30, 2018 | -3.70% |
| Jun 30, 2018 | 101.92% |
| Mar 31, 2018 | 303.37% |
| Dec 31, 2017 | -84.11% |
| Sep 30, 2017 | 59.30% |
| Jun 30, 2017 | 1,557.75% |
| Mar 31, 2017 | -95.87% |
| Dec 31, 2016 | 143.27% |
| Sep 30, 2016 | -27.50% |